Researchers are excited about the medication , a novel dual agonist showing promising outcomes in initial trials for body reduction . It works by impacting both pathways : GLP-1 and GIP, these, when https://nikolaswwqa476063.p2blogs.com/39213475/a-new-hope-for-body-loss